Adherence to treatment for tobacco dependence: Association with smoking abstinence and predictors of adherence

Nicotine and Tobacco Research

Volumn 12, Issue 6, 2010, Pages 574-581

  Hays, J Taylor ^a   Leischow, Scott J ^b   Lawrence, David ^c   Lee, Theodore C ^c  

^a Mayo Clinic   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; CARBON MONOXIDE; PLACEBO; VARENICLINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG WITHDRAWAL; HUMAN; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; PRIORITY JOURNAL; SMOKING CESSATION; SUSTAINED DRUG RELEASE; TOBACCO DEPENDENCE; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; ADULT; AGED; BENZAZEPINES; BUPROPION; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; QUINOXALINES; SMOKING CESSATION; TOBACCO USE DISORDER; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77955249408     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntq047     Document Type: Article

References (28)

1. Alterman, A. I., Gariti, P., Cook, T. G., & Cnaan, A. (1999). Nicodermal patch adherence and its correlates. Drug and Alcohol Dependence, 53, 159-165.
2. Baltieri, D. A., Daro, F. R., Ribeiro, P. L., & De Andrade, A. G. (2009). The role of alcoholic beverage preference in the severity of alcohol dependence and adherence to the treatment. Alcohol, 43, 185-195.
3. Banta, J. E., Haskard, K. B., Haviland, M. G., Williams, S. L., Werner, L. S., Anderson, D. L., et al. (2009). Mental health, binge drinking, and antihypertension medication adherence. American Journal of Health Behavior, 33, 158-171.
4. Bryson, C. L., Au, D. H., Sun, H., Williams, E. C., Kivlahan, D. R., & Bradley, K. A. (2008). Alcohol screening scores and medication nonadherence. Annals of Internal Medicine, 149, 795-804.
5. DiMatteo, M. R. (2004). Variations in patients' adherence to medical recommendations: A quantitative review of 50 years of research. Medical Care, 42, 200-209.
6. DiMatteo, M. R., Haskard, K. B., & Williams, S. L. (2007). Health beliefs, disease severity, and patient adherence: A metaanalysis. Medical Care, 45, 521-528.
7. DiMatteo, M. R., Lepper, H. S., & Croghan, T. W. (2000). Depression is a risk factor for noncompliance with medical treatment: Meta-analysis of the effects of anxiety and depression on patient adherence. Archives of Internal Medicine, 160, 2101-2107.
8. Feeney, G. F., Connor, J. P., Young, R. M., Tucker, J., & Czajkowski, F. (2001). Adherence with naltrexone prescription advice in hospital outpatient alcohol rehabilitation programme. Journal of Clinical Pharmacy and Therapeutics, 26, 73-79.
9. Fiore, M. C., Jaén, C. R., Baker, T. B., Bailey, W. C., Benowitz, N. L., Curry, S. J., et al. (2008). Treating tobacco use and dependence: 2008 update. Clinical practice guideline. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service.
10. Fish, L. J., Peterson, B. L., Namenek Brouwer, R. J., Lyna, P., Oncken, C. A., Swamy, G. K., et al. (2009). Adherence to nicotine replacement therapy among pregnant smokers. Nicotine & Tobacco Research, 11, 514-518.
11. Gonzales, D., Rennard, S. I., Nides, M., Oncken, C., Azoulay, S., Billing, C. B., et al. (2006). Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: A randomized controlled trial. Journal of the American Medical Association, 296, 47-55.
12. Hajek, P., Tonnesen, P., Arteaga, C., Russ, C., & Tonstad, S. (2009). Varenicline in prevention of relapse to smoking: Effect of quit pattern on response to extended treatment. Addiction, 104, 1597-1602.
13. Haynes, R. B., Ackloo, E., Sahota, N., McDonald, H. P., & Yao, X. (2008). Interventions for enhancing medication adherence. Cochrane Database of Systematic Reviews, CD000011.
14. Jackevicius, C. A., Mamdani, M., & Tu, J. V. (2002). Adherence with statin therapy in elderly patients with and without acute coronary syndromes. Journal of the American Medical Association, 288, 462-467.
15. Jorenby, D. E., Hays, J. T., Rigotti, N. A., Azoulay, S., Watsky, E. J., Williams, K. E., et al. (2006). Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: A randomized controlled trial. Journal of the American Medical Association, 296, 56-63.
16. Kripalani, S., Yao, X., & Haynes, R. B. (2007). Interventions to enhance medication adherence in chronic medical conditions: A systematic review. Archives of Internal Medicine, 167, 540-550.
17. Lee, J. K., Grace, K. A., & Taylor, A. J. (2006). Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: A randomized controlled trial. Journal of the American Medical Association, 296, 2563-2571.
18. Leischow, S. J., Muramoto, M. L., Cook, G. N., Merikle, E. P., Castellini, S. M., & Otte, P. S. (1999). OTC nicotine patch: Effectiveness alone and with brief physician intervention. American Journal of Health Behavior, 23, 61-69.
19. Leischow, S. J., Ranger-Moore, J., Muramoto, M. L., & Matthews, E. (2004). Effectiveness of the nicotine inhaler for smoking cessation in an OTC setting. American Journal of Health Behavior, 28, 291-301.
20. McDonald, H. P., Garg, A. X., & Haynes, R. B. (2002). Interventions to enhance patient adherence to medication prescriptions: Scientific review. Journal of the American Medical Association, 288, 2868-2879.
21. Oslin, D. W., Pettinati, H., & Volpicelli, J. R. (2002). Alcoholism treatment adherence: Older age predicts better adherence and drinking outcomes. American Journal of Geriatric Psychiatry, 10, 740-747.
22. Rasmussen, J. N., Chong, A., & Alter, D. A. (2007). Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. Journal of the American Medical Association, 297, 177-186.
23. Reid, S. C., Teesson, M., Sannibale, C., Matsuda, M., & Haber, P. S. (2005). The efficacy of compliance therapy in pharmacotherapy for alcohol dependence: A randomized controlled trial. Journal of Studies on Alcohol, 66, 833-841.
24. Rohsenow, D. J., Colby, S. M., Monti, P. M., Swift, R. M., Martin, R. A., Mueller, T. I., et al. (2000). Predictors of compliance with naltrexone among alcoholics. Alcoholism, Clinical and Experimental Research, 24, 1542-1549.
25. Schedlbauer, A., Schroeder, K., Peters, T. J., & Fahey, T. (2004). Interventions to improve adherence to lipid lowering medication. Cochrane Database of Systematic Reviews, CD004371.
26. Schroeder, K., Fahey, T., & Ebrahim, S. (2004). Interventions for improving adherence to treatment in patients with high blood pressure in ambulatory settings. Cochrane Database of Systematic Reviews, CD004804.
27. Shiffman, S., Sweeney, C. T., Ferguson, S. G., Sembower, M. A., & Gitchell, J. G. (2008). Relationship between adherence to daily nicotine patch use and treatment efficacy: Secondary analysis of a 10-week randomized, double-blind, placebo-controlled clinical trial simulating over-the-counter use in adult smokers. Clinical Therapeutics, 30, 1852-1858.
28. Ziedonis, D., Hitsman, B., Beckham, J. C., Zvolensky, M., Adler, L. E., Audrain-McGovern, J., et al. (2008). Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report. Nicotine & Tobacco Research, 10, 1691-1715.